Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine adjunctive therapy in severe falciparum malaria
ACTRN12612000571875Phase 2Recruiting
- Sponsor
- Menzies School of Health Research
- Start
- Jun 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of arginine in Malaria (2 arms), sponsored by Menzies School of Health Research. Primary endpoints: Area under the curve for microvascular reactivity by RH-PAT and Lactate clearance area under the curve. Started Jun 2012; status: recruiting.
02
Drugs
arginine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12612000571875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000571875.